Régis Bordet Selected Research

Baclofen

12/2019	A capture-recapture method for estimating the incidence of off-label prescriptions: the example of baclofen for alcohol use disorder in France.
5/2019	Acute Psychosis Related to Baclofen in a Patient Treated for Binge Eating Disorder Highlights the Urgent Need to Regulate Off-Label Prescriptions.
4/2018	On-the-ground application of the 'temporary recommendation for use' regulatory measure on off-label use of baclofen for alcohol dependence in France: a regional survey of community pharmacies.
1/2018	Full-Profile Pharmacokinetic Study of High Dose Baclofen in Subjects With Alcohol Use Disorder.
2/2017	Phone-based safety monitoring of the first year of baclofen treatment for alcohol use disorder: the BACLOPHONE cohort study protocol.
1/2017	Authors' Reply to Alain Braillon's Comment on "Proactive regional pharmacovigilance system versus national spontaneous reporting for collecting safety data on concerning off-label prescribing practices: An example with baclofen and alcohol dependence in France''.
1/2017	Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France.
1/2017	The dose-effect relationship of baclofen in alcohol dependence: A 1-year cohort study.
10/2015	Baclofen for alcohol dependence: Relationships between baclofen and alcohol dosing and the occurrence of major sedation.
4/2015	Attitudes of community pharmacists to off-label prescribing of baclofen in Northern France.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Régis Bordet Research Topics

Disease

40	Stroke (Strokes) 01/2022 - 05/2002
26	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2005
20	Cognitive Dysfunction 12/2021 - 09/2009
20	Alcoholism (Alcohol Abuse) 12/2019 - 02/2012
16	Brain Ischemia (Cerebral Ischemia) 05/2018 - 01/2003
15	Dementia (Dementias) 01/2022 - 01/2003
14	Ischemic Stroke 01/2021 - 05/2002
14	Ischemia 05/2014 - 04/2003
12	Parkinson Disease (Parkinson's Disease) 10/2019 - 11/2004
11	Infarction (Infarctions) 01/2021 - 04/2003
9	Inflammation (Inflammations) 01/2022 - 07/2003
5	Hypertension (High Blood Pressure) 01/2020 - 05/2002
5	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2019 - 01/2016
5	Disease Progression 01/2019 - 12/2013
5	Cerebral Hemorrhage 01/2019 - 12/2003
5	Hemorrhage 01/2019 - 12/2003
4	Schizophrenia (Dementia Praecox) 03/2021 - 01/2008
4	Seizures (Absence Seizure) 01/2021 - 09/2012
3	Body Weight (Weight, Body) 01/2021 - 02/2008
3	Weight Gain 01/2018 - 04/2011
3	Cerebral Infarction 11/2009 - 07/2003
3	Erectile Dysfunction 06/2009 - 03/2006
3	Brain Infarction 02/2009 - 01/2003
3	Atherosclerotic Plaque (Atheroma) 01/2007 - 10/2003
3	Shock 01/2006 - 08/2004
2	Nervous System Diseases (Neurological Disorders) 01/2022 - 09/2012
2	Brain Diseases (Brain Disorder) 03/2021 - 11/2007
2	Glucose Intolerance 10/2019 - 01/2018
2	Binge-Eating Disorder (Binge Eating Disorder) 05/2019 - 09/2012
2	Psychotic Disorders (Schizoaffective Disorder) 05/2019 - 01/2014
2	Atrophy 01/2019 - 01/2019
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2018 - 02/2012
2	Overweight 01/2018 - 04/2011
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 01/2014
2	Sleep Deprivation 01/2018 - 01/2017
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2017 - 01/2015
2	Drug-Related Side Effects and Adverse Reactions 01/2017 - 07/2014
2	Neoplasms (Cancer) 10/2016 - 01/2003
2	Brain Injuries (Brain Injury) 05/2016 - 06/2009

Drug/Important Bio-Agent (IBA)

27	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2005
22	Baclofen FDA LinkGeneric 12/2019 - 11/2010
14	Pharmaceutical PreparationsIBA 03/2021 - 01/2005
12	Neuroprotective AgentsIBA 06/2014 - 04/2003
11	Amyloid (Amyloid Fibrils)IBA 01/2022 - 03/2005
11	LipidsIBA 10/2019 - 01/2003
11	Fenofibrate (CiL)FDA LinkGeneric 05/2016 - 07/2003
9	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 12/2003
6	Biological ProductsIBA 01/2021 - 07/2003
6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2015 - 09/2003
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 05/2002
5	PPAR alphaIBA 01/2015 - 07/2003
5	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 05/2010 - 11/2004
4	Antipsychotic Agents (Antipsychotics)IBA 03/2021 - 04/2011
4	Atorvastatin (Lipitor)FDA Link 01/2021 - 03/2007
4	CholesterolIBA 01/2021 - 05/2002
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2005
4	Memantine (Namenda)FDA Link 05/2020 - 05/2013
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2018 - 08/2004
4	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2018 - 01/2008
4	PotassiumIBA 01/2013 - 04/2003
4	LipopolysaccharidesIBA 01/2006 - 04/2003
3	BenzodiazepinesIBA 12/2021 - 02/2014
3	Blood Proteins (Serum Proteins)IBA 01/2021 - 11/2019
3	Donepezil (Aricept)FDA LinkGeneric 05/2020 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 11/2013
3	Peptides (Polypeptides)IBA 01/2019 - 09/2009
3	IronIBA 10/2018 - 07/2014
3	EnzymesIBA 01/2018 - 07/2003
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 06/2014 - 07/2009
3	EndotoxinsIBA 01/2006 - 08/2004
3	Thromboplastin (Tissue Factor)IBA 01/2006 - 10/2003
3	Escherichia coli endotoxinIBA 01/2006 - 08/2004
3	ApolipoproteinsIBA 09/2005 - 07/2003
2	Oxygen (Dioxygen)IBA 08/2022 - 02/2012
2	ORALIT (ORS)IBA 01/2022 - 01/2021
2	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 09/2009
2	A-factor (Streptomyces)IBA 10/2019 - 04/2015
2	HDL CholesterolIBA 01/2018 - 09/2012
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2016 - 01/2014
2	Simvastatin (Zocor)FDA LinkGeneric 05/2016 - 03/2007
2	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2015 - 04/2005
2	Levodopa (L Dopa)FDA LinkGeneric 05/2015 - 05/2013
2	Methylphenidate (Ritalin)FDA LinkGeneric 05/2015 - 07/2012
2	gamma-Aminobutyric Acid (GABA)IBA 07/2014 - 05/2014
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2014 - 01/2003
2	GABA-B ReceptorsIBA 05/2014 - 11/2010
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2014 - 07/2007
2	Protein Disulfide-IsomerasesIBA 01/2014 - 06/2009
2	oxidized low density lipoproteinIBA 09/2012 - 09/2005
2	Antidepressive Agents (Antidepressants)IBA 06/2011 - 02/2009
2	Potassium Channels (Potassium Channel)IBA 02/2011 - 11/2008
2	Adenosine Triphosphate (ATP)IBA 02/2011 - 11/2008
2	Diazoxide (Hyperstat)FDA Link 02/2011 - 11/2008
2	mitochondrial K(ATP) channelIBA 02/2011 - 11/2008
2	BezafibrateIBA 05/2010 - 03/2007
2	Fibric Acids (Fibrates)IBA 05/2010 - 01/2003

Therapy/Procedure

13	Therapeutics 08/2022 - 05/2002
8	Off-Label Use 04/2018 - 09/2012
4	Thrombolytic Therapy 05/2018 - 03/2013
3	Secondary Prevention 01/2020 - 02/2018